We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

21 hedge funds and large institutions have $875K invested in NKGen Biotech, Inc. Warrants in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

59% more capital invested

Capital invested by funds: $551K → $875K (+$323K)

40% less funds holding

Funds holding: 35 → 21 (-14)

88% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 16

Holders
21
Holders Change
-14
Holders Change %
-40%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
16
Calls
$12K
Puts
–
Net Calls
+$12K
Net Calls Change
-$9K

Top Buyers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
+$63.8K
2
ETH
Exos TFP Holdings
New York
+$27.6K
3
UBS Group
UBS Group
Switzerland
+$5.33K
4
CS
Clear Street
New York
+$66

Top Sellers

Rank Fund Capital Flow
1
RCM
Radcliffe Capital Management
Pennsylvania
-$25.1K
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$22.8K
3
KL
KIM LLC
Kansas
-$21K
4
6CM
683 Capital Management
New York
-$20K
5
KC
Kepos Capital
New York
-$17K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Rivernorth Capital Management
Florida
$255K – – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$71.8K – – –
SCM
3
Shaolin Capital Management
Florida
$65K +$63.8K +165,515 New
BNP Paribas Financial Markets
4
BNP Paribas Financial Markets
France
$59.2K – – –
ETH
5
Exos TFP Holdings
New York
$57.7K +$27.6K +71,654 +96%
Balyasny Asset Management
6
Balyasny Asset Management
Illinois
$55.2K -$41 -107 -0.1%
AA
7
AQR Arbitrage
Connecticut
$50.6K – – –
PC
8
Periscope Capital
Ontario, Canada
$47.3K – – –
Jane Street
9
Jane Street
New York
$39.5K – – –
PSAMP
10
P. Schoenfeld Asset Management (PSAM)
New York
$31.6K – – –
TCA
11
Taconic Capital Advisors
New York
$27.6K – – –
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$19.7K – – –
MTCM
13
Mint Tower Capital Management
Netherlands
$16K – – –
AIMCA
14
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$15.8K – – –
JFG
15
Jefferies Financial Group
New York
$13.8K – – –
SCM
16
Saba Capital Management
New York
$12.3K – – –
ACM
17
Atalaya Capital Management
New York
$11.7K – – –
BI
18
Bulldog Investors
New Jersey
$7.89K – – –
JP Morgan Chase
19
JP Morgan Chase
New York
$7.29K – – –
UBS Group
20
UBS Group
Switzerland
$5.46K +$5.33K +13,836 New
PI
21
PEAK6 Investments
Illinois
$4.36K – – –
CS
22
Clear Street
New York
$194 +$66 +171 +53%
RCM
23
Radcliffe Capital Management
Pennsylvania
– -$25.1K -120,000 Closed
6CM
24
683 Capital Management
New York
– -$20K -100,000 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
25
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$22.8K -100,000 Closed
1
2

NKGNW Hedge Fund Activity: Q3 2023 in Review

21 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q3 2023, worth a combined $875K — up 59% from $551K a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of NKGNW and 2 opened new positions — a net loss of 14 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $63.8K. The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $25.1K sold.

  • 21 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q3 2023, down from 35 in Q2 2023.
  • Funds reported $875K of NKGen Biotech, Inc. Warrants stock for Q3 2023, up 59% quarter-over-quarter.
  • 2 funds opened new NKGen Biotech, Inc. Warrants positions in Q3 2023 and 16 closed out, a net change of -14 holders.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q3 2023 was Shaolin Capital Management, an estimated $63.8K added.
  • The largest NKGen Biotech, Inc. Warrants seller in Q3 2023 was Radcliffe Capital Management, an estimated $25.1K sold.

Based on aggregated 13F filings for Q3 2023.